Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Gabapentin borderline personality disorder use in patients with hepatic impairment tardive dyskinesia
Galactorrhea
Galantamine mild cognitive impairment alzheimerâ™s disease
gamma-glutamyl transferase (GGT), psychotropic agent effects
gamma-hydroxybutyrate (GHB) and gamma-butyrolactone planned elective withdrawal withdrawal management dependence unplanned withdrawal withdrawal syndrome
gastrointestinal bleeding, SSRI risks
Gastrointestinal disturbances, antiretrovirals
Gastrointestinal irritant drugs, increased risk of bleeding in hepatic impairment
gastro-oesophageal reflux disease (GERD) 220
generalised anxiety disorder (GAD) NICE guidelines specific drugs used valproate treatment pregabalin SSRIs/SNRIs
General Medical Council, UK, guidelines for prescribers, medical conditions and safe driving
Genetics of cytochrome function
Genetic testing for treatment agranulocytosis Genetic testing for clozapine treatment benign ethnic neutropenia
Gestational diabetes, antipsychotics risk
Ginkgo biloba Dementia Alternatives to clozapine Optimising clozapine treatment Treatment of tardive dyskinesia
gabapentinoids (GABA analogues), addiction/physical dependence and withdrawal
Gambling disorder
Gastrointestinal disorders, drug safety in older patients/dementia
Gastrointestinal hypomotility, clozapine-induced
Gastrointestinal necrosis
General Guidelines
Generalised seizures, severe alcohol withdrawal
General recommendations for prescribing intramuscular clozapine
Genetic testing for clozapine treatment
genitourinary symptoms of menopause (GSM) 857
glomerular filtration rate (GFR), estimation for renal impairment assessment
Glucocorticoid receptor blocking, psychotic depression treatment
Glucose homeostasis SSRIs improving control antidepressant effects
Glucose in blood, psychotropic agent effects
Glucose tolerance impairment, antipsychotic-related Switching antipsychotics Diabetes and impaired glucose tolerance